BillionaireNet
Boehringer
Albert Boehringer
Rank #668
GERMANYHealthcarePharmaceuticals

Albert Boehringer

Net Worth
$5.807B
0% (24h)
Albert Boehringer (born August 11, 1861) is a German chemist and industrialist. He is the founder of Boehringer Ingelheim, one of the world's largest privately-held pharmaceutical companies, a wealth source built on pharmaceuticals. In 1885, he started a small chemical factory in Ingelheim am Rhein, Germany, which has since grown to a global enterprise. His career began with the production of tartaric acid and evolved to industrial production of lactic acid through bacterial fermentation, pioneering large-scale biotechnological production. His achievements include launching the firm's first pharmaceutical specialty and establishing the company's foundation for long-term success. As of 2024, he remains a key figure in the family-owned business that employs over 53,000 people worldwide.

The Full Dossier

Early Life

Albert Boehringer was born on August 11, 1861, in Stuttgart, Germany. He studied chemistry, laying the groundwork for his future endeavors. In 1885, at the age of 24, he purchased a small tartar factory in Nieder-Ingelheim, Germany, marking the beginning of his entrepreneurial journey.

Rise to Success

Boehringer's vision and scientific acumen were key to his success. The company, initially named Albert Boehringer, Chemische Fabrik, started with 28 employees and focused on producing tartaric acid salts for various industries. A pivotal moment came in the 1890s when Boehringer pioneered the industrial production of lactic acid through bacterial fermentation. This innovation propelled the company forward, establishing it as a pioneer in large-scale biotechnological production. The company was renamed C. H. Boehringer Sohn in 1893. His discovery enabled the company to mass-produce lactic acid, which was in high demand. The company launched its first pharmaceutical specialty, Laudanon, in 1912.

Key Business Strategies

Boehringer's business strategy focused on long-term sustainability and research. The company invested in research and development, expanding its product line and international presence. This expansion included subsidiaries and production facilities across the globe. By the time of his death in 1939, the company had grown to employ 1,500 people, a testament to his strategic vision.

Philanthropy

While specific amounts are unavailable, Boehringer was known for prioritizing employee welfare. This included health insurance, paid leave, and a company pension scheme, reflecting his commitment to his workforce.

Career Timeline

1912/1915

Launched Laudanon

Launched the company's first pharmaceutical specialty, marking its entry into drug production.

1893

Pioneered Lactic Acid Production

Discovered a method for industrial production of lactic acid through bacterial fermentation, a pioneering achievement in biotechnology.

1885

Founded Boehringer Ingelheim

Purchased a tartar factory in Nieder-Ingelheim, Germany, laying the foundation for the pharmaceutical company.

Philanthropic Impact

Employee BenefitsUndisclosed

Employee Welfare

Prioritized employee well-being through health insurance, paid leave, and pension schemes.

Wealth Trajectory